Evaluation of the Anti-Inflammatory Activity of Enzymatic Hydrolysis Peptide SEP-3 from Skipjack (Katsuwonus pelamis) Based on NF-kappa B and MAPK Pathways

Chong Yi,Yue Wu,Zhi-gao Wang,Kun-mei Wang,Ze-kun Zhang,Bin Wang,Hong-yu Luo
DOI: https://doi.org/10.1080/10498850.2022.2133582
2022-01-01
Journal of Aquatic Food Product Technology
Abstract:The skipjack enzymatic peptide 3 (SEP-3) has been previously isolated and purified from a byproduct of skipjack. In this paper, the anti-inflammatory activity and mechanism of SEP-3 in RAW264.7 macrophages activated by lipopolysaccharide (LPS) were investigated. We found that SEP-3 enhanced the proliferation and phagocytic capacity of RAW264.7 macrophages and suppressed the expression of pro-inflammatory cytokines IL-1 beta, IL-6, and TNF-alpha. Cells treated with SEP-3 showed decreased phosphorylation of ERK, p38, JNK, NF-kappa B p65, and I kappa B alpha and inhibited NF-kappa B and mitogen-activated protein kinases (MAPK) inflammatory pathways. Optimal dosage was determined, and modified outcome was identified when SEP-3 treatment was combined with indomethacin. In addition, the metabolites of the dominant microflora of mice gavaged by SEP-3 showed antioxidant activity in vitro. Therefore, we conclude that SEP-3 extracted from skipjack may have a direct or indirect anti-inflammatory effect and can be used as an adjuvant drug to treat inflammatory diseases.
What problem does this paper attempt to address?